Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC
Andrea Arnett(Mayo Clinic), Kenneth W. Merrell(Mayo Clinic), Sean S. Park(Mayo Clinic), Terence T. Sio(The University of Texas MD Anderson Cancer Center), Benjamin Mou(University of British Columbia), Christopher L. Hallemeier(Mayo Clinic in Arizona), Yolanda I. Garces(Mayo Clinic), Katy Nelson(Mayo Clinic), Kenneth R. Olivier(Mayo Clinic), Dawn Owen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 32
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Oesophageal cancer
|The Lancet|2024|265